Table 3.
Characteristics of Participants in Step 3 Single Arm Pilot Study and Step 4 Stratified Focus Groups and Individual Interviews.
| Step 3 (N = 23) | Step 4 (N = 28) | |
|---|---|---|
| N (%)/Mean (Range) | ||
| Age (years) | 61.0 (35-88) | 53.1 (23-74) |
| Gender (female) | 20 (86.9%) | 20 (71.4%) |
| Race | ||
| Asian | 0 (0%) | 2 (7.1%) |
| African American | 2 (8.7%) | 1 (3.6%) |
| Multiracial | 1 (4.3%) | 0 (0%) |
| White | 20 (86.9%) | 24 (85.7%) |
| Ethnicity (Hispanic) | 0 (0%) | 1 (3.6%) |
| Cancer site | ||
| Blood/hematologic malignancy | 1 (4.3%) | 10 (35.7%) |
| Breast | 9 (39.1%) | 9 (32.1%) |
| Colon/gastric | 9 (39.1%) | 5 (17.9%) |
| Gynecological | 3 (13.0%) | 4 (14.3%) |
| Prostate | 0 (0%) | 1 (3.6%) |
| Kidney | 0 (0%) | 1 (3.6%) |
| Lung | 2 (8.7%) | 1 (3.6%) |
| Melanoma | 1 (4.3%) | 1 (3.6%) |
| Retinoblastoma | 0 (0%) | 1 (3.6%) |
| Sinus tumor | 0 (0%) | 1 (3.6%) |
| Thyroid | 0 (0%) | 1 (3.6%) |
| Time since treatment (months) | 12.3 (3-30) | 43.7 (3-252) |
| Cancer treatment history | ||
| Chemotherapy | 18 (78.3%) | 18 (64.3%) |
| Radioactive iodine | 8 (34.8%) | 1 (3.6%) |
| Stem cell transplant | 0 (0%) | 1 (3.6%) |
| Surgery | 22 (95.6%) | 20 (71.4%) |
aSurvivors could have received treatment for more than 1 cancer.